The purpose of this competing renewal is to continue to investigate the host genetic basis for recovery from hepatitis C virus (HCV) infection. There is substantial evidence that there is a host genetic basis for HCV recovery. To investigate this hypothesis, we established a panel that included DNA from 250 persons who cleared HCV infection and 500 matched controls and, in the initial years of R01 DA13324, demonstrated the importance of certain HLA polymorphisms with HCV recovery. In addition, associations were detected between HCV recovery and polymorphisms in certain immune response genes, such as the counter regulatory T cell response gene cytotoxic T lymphocyte antigen 4. Nonetheless, much of the genetic basis for HCV recovery remains unknown. Recent progress in HCV pathogenesis has suggested a number of additional molecular pathways. In addition, completion of the haplotype map of the human genome provides unprecedented power to investigate the complex interactions between the genetics of the immune response and the outcome of HCV infection. We plan to build on these discoveries in forthcoming years of this research program by first doubling the size of what is already the largest DNA panel of HCV recovery. Then, we plan to continue detailed studies of the genetics of interferon regulatory factors, T cell regulatory pathways, and HLA-related mechanisms. Given the established collaborative research networks and the power of scientific methods, we anticipate a high likelihood of success. ? ? ?

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Project (R01)
Project #
Application #
Study Section
AIDS Clinical Studies and Epidemiology Study Section (ACE)
Program Officer
Khalsa, Jagjitsingh H
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Vergara, Candelaria; Parker, Margaret M; Franco, Liliana et al. (2018) Genotype imputation performance of three reference panels using African ancestry individuals. Hum Genet 137:281-292
Boelen, Lies; Debebe, Bisrat; Silveira, Marcos et al. (2018) Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell-mediated control of HIV-1, HCV, and HTLV-1. Sci Immunol 3:
Vergara, C; Thio, C; Latanich, R et al. (2017) Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections. Genes Immun 18:82-87
Huang, Hailiang; Duggal, Priya; Thio, Chloe L et al. (2017) Fine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection. Sci Rep 7:15843
Vergara, Candelaria; Thio, Chloe L; Thomas, David et al. (2016) Polymorphisms in melanoma differentiation-associated gene 5 are not associated with clearance of hepatitis C virus in a European American population. Hepatology 63:1061-2
Hiramine, Satoshi; Sugiyama, Masaya; Furusyo, Norihiro et al. (2015) A thymine-adenine dinucleotide repeat polymorphism near IL28B is associated with spontaneous clearance of hepatitis C virus. J Gastroenterol 50:1069-77
Kurbanov, Fuat; Kim, Yonghak; Latanich, Rachel et al. (2015) IFNL3 genotype is associated with differential induction of IFNL3 in primary human hepatocytes. Antivir Ther 20:805-14
Seaberg, Eric C; Witt, Mallory D; Jacobson, Lisa P et al. (2015) Spontaneous Clearance of the Hepatitis C Virus Among Men Who Have Sex With Men. Clin Infect Dis 61:1381-8
O'Brien, Thomas R; Pfeiffer, Ruth M; Paquin, Ashley et al. (2015) Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance. J Hepatol 63:1103-10
Chattergoon, Michael A; Latanich, Rachel; Quinn, Jeffrey et al. (2014) HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon. PLoS Pathog 10:e1004082

Showing the most recent 10 out of 50 publications